Pozen Starts Phase III Of MT 300 For Treating Severe Migraine Feb. 4, 2002 By Karen Young No Comments
Pozen Starts Phase III Of MT 300 For Treating Severe Migraine Feb. 4, 2002 By Karen Young No Comments
IntraBiotics Netting $13.9M From Private Deal For Iseganan Studies Jan. 31, 2002 By Karen Young No Comments
IntraBiotics Netting $13.9M From Private Deal For Iseganan Studies Jan. 31, 2002 By Karen Young No Comments
Achillion Closes $41M Round, Plans Phase III Trials This Year Jan. 29, 2002 By Karen Young No Comments Achillion Pharmaceuticals Inc. raised $41 million in a private round of financing that its CEO expects will allow it to take its lead anti-infective compound through Phase II trials and into Phase III before year’s end.Read More
